tiprankstipranks
Trending News
More News >
Altria Group Inc (MO)
NYSE:MO

Altria Group (MO) AI Stock Analysis

Compare
18,483 Followers

Top Page

MO

Altria Group

(NYSE:MO)

Select Model
Select Model
Select Model
Neutral 64 (OpenAI - 4o)
Rating:64Neutral
Price Target:
$62.00
▲(4.77% Upside)
Altria's overall stock score reflects strong earnings performance and attractive valuation, offset by technical weaknesses and financial leverage concerns. The company's strategic initiatives and high dividend yield are significant strengths, while declining cigarette volumes and market competition pose challenges.
Positive Factors
Cash Generation Ability
Strong cash generation supports Altria's ability to invest in growth initiatives and return value to shareholders through dividends and buybacks.
Strategic Initiatives
Collaborations like the one with KT&G enhance Altria's growth prospects by expanding its product offerings and market reach.
Product Diversification
The launch of on! PLUS reflects Altria's efforts to diversify its product portfolio, catering to changing consumer preferences towards smoke-free products.
Negative Factors
Declining Cigarette Volumes
Declining cigarette volumes indicate a shrinking core market, which could impact long-term revenue unless offset by growth in other segments.
Financial Leverage
High financial leverage limits Altria's flexibility and increases risk, potentially affecting its ability to finance future growth initiatives.
Intensified Competition
Increased competition in the nicotine pouch market pressures margins and could hinder Altria's efforts to grow its market share in this segment.

Altria Group (MO) vs. SPDR S&P 500 ETF (SPY)

Altria Group Business Overview & Revenue Model

Company DescriptionAltria Group, Inc. is a leading American corporation specializing in the manufacture and marketing of tobacco products and related services. Headquartered in Richmond, Virginia, Altria operates primarily through segments that include smokeable products, smokeless products, and wine. The company is known for its well-established brands, including Marlboro cigarettes, and has diversified its portfolio to include products like oral tobacco and heated tobacco products, as well as investments in alternative nicotine delivery systems.
How the Company Makes MoneyAltria generates revenue primarily through the sale of its tobacco products, which include cigarettes and smokeless tobacco. The company's smokeable products segment, led by Marlboro, represents a significant portion of its income, driven by both domestic sales and brand loyalty. Additionally, Altria earns revenue from its smokeless products, such as Copenhagen and Skoal, which have seen increased demand in recent years. The company has also invested in non-combustible product offerings, including e-vapor and heated tobacco products, which contribute to its revenue as consumer preferences shift. Key partnerships, such as its stake in Cronos Group, a cannabis company, and investments in innovative smoke-free alternatives, further enhance its revenue potential. Overall, Altria's earnings are influenced by regulatory factors, market trends, and its strategic focus on diversifying its product offerings.

Altria Group Key Performance Indicators (KPIs)

Any
Any
Smokeable Products Sticks Shipped
Smokeable Products Sticks Shipped
Indicates the volume of cigarette products distributed, reflecting consumer demand trends and market penetration for Altria's smokeable segment.
Chart InsightsAltria's smokeable products segment is experiencing a significant decline in cigarette volumes, with Marlboro and other premium brands seeing consistent decreases. Despite Marlboro's leadership in the premium segment, the decline aligns with broader industry trends and regulatory pressures. The earnings call highlighted a 10.2% drop in domestic cigarette volumes in Q2, emphasizing the need for strategic pivots. Altria is focusing on growth in the oral tobacco segment, particularly with on! nicotine pouches, which could offset some of the declines in traditional cigarette sales.
Data provided by:The Fly

Altria Group Earnings Call Summary

Earnings Call Date:Oct 30, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Jan 29, 2026
Earnings Call Sentiment Neutral
Altria's earnings call presented a strong financial performance with increased earnings and strategic initiatives such as a dividend increase, share repurchase program, and new product launches. However, challenges like cigarette volume decline and intensified competition in the nicotine pouch market were notable. Regulatory advancements and new collaborations were positive highlights.
Q3-2025 Updates
Positive Updates
Strong Financial Performance
Altria delivered a 3.6% increase in adjusted diluted earnings per share for the third quarter and a 5.9% increase for the first nine months.
Dividend and Share Repurchase Program
In August, Altria announced its 60th dividend increase in 56 years and expanded its share repurchase program to $2 billion.
On! PLUS Launch
Helix launched on! PLUS in Florida, North Carolina, and Texas, with positive consumer feedback indicating potential for premium positioning.
Regulatory Progress
The FDA's pilot program aims to accelerate PMTA reviews for oral nicotine pouches, including applications for on! PLUS.
KT&G Collaboration
Altria announced a collaboration with KT&G to explore global demand for nicotine pouch products and opportunities in U.S. non-nicotine markets.
Negative Updates
Cigarette Volume Decline
Smokeable products segment reported an 8.2% decline in domestic cigarette volumes for the third quarter.
Intensified Competition in Nicotine Pouches
Competitors' promotional activity led to a decline in retail prices for nicotine pouches by 7% nationally.
E-Vapor Market Challenges
The e-vapor market remains saturated with illicit products, and NJOY and JUUL initiated litigation against each other.
Company Guidance
During the Altria Group's 2025 Third Quarter Earnings Conference Call, the company provided guidance highlighting strong financial performance and strategic advancements. For the third quarter, Altria reported a 3.6% increase in adjusted diluted earnings per share, with the smokeable products segment showing a 0.7% growth in adjusted operating company's income, reaching nearly $3 billion. The adjusted OCI margins expanded to 64.4%, despite a domestic cigarette volume decline of 8.2%. The oral tobacco segment, bolstered by the Helix brand, particularly on! nicotine pouches, saw a retail share increase to 8.7%, with shipment volumes growing by 1% despite competitive pressures. Altria raised the lower end of its 2025 guidance range, now anticipating adjusted diluted EPS growth of 3.5% to 5%. The company also highlighted its strategic collaboration with KT&G to explore international markets and non-nicotine products, alongside regulatory advancements for its smoke-free portfolio, including the launch of on! PLUS and regulatory filings for heated tobacco products. Altria remains committed to shareholder returns, evidenced by its recent dividend increase and share repurchase program expansion.

Altria Group Financial Statement Overview

Summary
Altria Group shows strong profitability and cash flow generation, with high margins and efficient cash conversion. However, declining revenue and significant financial leverage, evidenced by negative equity and high debt levels, pose risks to financial stability.
Income Statement
65
Positive
Altria Group's income statement shows strong profitability with a high gross profit margin of 71.98% and a net profit margin of 43.98% for the TTM period. However, the company is experiencing a negative revenue growth rate of -0.46%, indicating a decline in sales. The EBIT and EBITDA margins remain robust at 58.56% and 59.98%, respectively, showcasing efficient cost management despite the revenue decline.
Balance Sheet
40
Negative
The balance sheet reveals significant financial leverage with a negative stockholders' equity, resulting in a concerning debt-to-equity ratio of -9.71 for the TTM period. The return on equity is also negative at -3.05%, reflecting challenges in generating returns for shareholders. The equity ratio is not calculable due to negative equity, highlighting potential financial instability.
Cash Flow
75
Positive
Cash flow analysis indicates strong cash generation capabilities, with a free cash flow growth rate of 7.82% for the TTM period. The operating cash flow to net income ratio is 1.42, and the free cash flow to net income ratio is 0.98, suggesting efficient cash conversion and solid liquidity. These metrics demonstrate the company's ability to generate cash despite revenue challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue20.17B20.44B20.50B20.69B21.11B20.84B
Gross Profit14.52B14.37B14.28B14.25B13.99B13.02B
EBITDA12.10B15.07B12.35B8.74B5.26B8.37B
Net Income8.87B11.26B8.13B5.76B2.48B4.47B
Balance Sheet
Total Assets35.01B35.18B38.57B36.95B39.52B47.41B
Cash, Cash Equivalents and Short-Term Investments3.47B3.13B3.69B4.03B4.54B4.95B
Total Debt25.70B24.93B26.23B26.68B28.04B29.47B
Total Liabilities37.60B37.37B42.06B40.88B41.13B44.49B
Stockholders Equity-2.65B-2.24B-3.54B-3.97B-1.61B2.84B
Cash Flow
Free Cash Flow11.57B8.61B9.09B8.05B8.24B8.15B
Operating Cash Flow11.75B8.75B9.29B8.26B8.40B8.38B
Investing Cash Flow-203.00M2.17B-1.28B782.00M1.21B-143.00M
Financing Cash Flow-3.56B-11.49B-8.37B-9.54B-10.03B-5.40B

Altria Group Technical Analysis

Technical Analysis Sentiment
Positive
Last Price59.18
Price Trends
50DMA
60.22
Negative
100DMA
62.43
Negative
200DMA
59.64
Negative
Market Momentum
MACD
-0.19
Negative
RSI
51.88
Neutral
STOCH
72.77
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MO, the sentiment is Positive. The current price of 59.18 is above the 20-day moving average (MA) of 58.55, below the 50-day MA of 60.22, and below the 200-day MA of 59.64, indicating a neutral trend. The MACD of -0.19 indicates Negative momentum. The RSI at 51.88 is Neutral, neither overbought nor oversold. The STOCH value of 72.77 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MO.

Altria Group Risk Analysis

Altria Group disclosed 23 risk factors in its most recent earnings report. Altria Group reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Altria Group Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
$2.89B27.344.71%0.34%51.49%21.43%
70
Neutral
$1.36B12.287.72%5.91%3.01%-7.14%
69
Neutral
$2.11B39.0322.54%0.27%6.71%8.16%
64
Neutral
$99.60B11.327.02%-0.96%-11.42%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
61
Neutral
$245.87B28.613.59%7.72%-12.45%
59
Neutral
$124.27B31.715.97%5.21%0.48%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MO
Altria Group
59.18
9.79
19.82%
BTI
British American Tobacco
57.17
22.79
66.29%
PM
Philip Morris
158.61
40.84
34.68%
UVV
Universal
55.13
3.92
7.65%
TPB
Turning Point Brands
109.14
50.67
86.66%
RLX
RLX Technology
2.33
0.38
19.49%

Altria Group Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
Altria Group Announces CEO Retirement and Successor
Neutral
Dec 11, 2025

On December 8, 2025, Altria Group announced the retirement of its CEO, William F. Gifford, Jr., effective May 14, 2026, after over 30 years of service. Salvatore Mancuso, currently the Executive Vice President and CFO, will succeed him as CEO, while Heather A. Newman will become the new CFO. This leadership transition is part of Altria’s long-term succession planning and aims to continue the company’s strategic vision of moving beyond smoking and achieving its 2028 Enterprise Goals.

Stock BuybackBusiness Operations and StrategyFinancial Disclosures
Altria Expands Share Repurchase Program to $2 Billion
Positive
Oct 30, 2025

On October 29, 2025, Altria’s Board of Directors authorized the expansion of its share repurchase program from $1 billion to $2 billion, set to expire on December 31, 2026. The company reported its third-quarter and nine-month results for 2025, highlighting resilience in its core tobacco businesses and advancements in its smoke-free portfolio. Altria also narrowed its full-year earnings guidance for 2025, expecting adjusted diluted EPS growth of 3.5% to 5.0% from 2024. The company continues to focus on returning value to shareholders through dividends and share repurchases while pursuing long-term growth in smoke-free and non-nicotine products.

Executive/Board Changes
Altria Group Announces Board Member Retirement
Neutral
Oct 9, 2025

On October 3, 2025, Altria Group announced the retirement of George Muñoz from its Board of Directors, effective after his current term ends. Muñoz, who has been with Altria since 2004, will not seek re-election at the 2026 Annual Meeting of Shareholders. His departure marks the end of over two decades of significant contributions to the company, where he held key roles such as Chair of the Compensation and Talent Development Committee. This change in leadership could impact Altria’s strategic direction as it continues to pursue its vision of a smoke-free future.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 09, 2025